Summary
The incidence of diverse types of nucleoli in peripheral blood lymphocytes was established in albino rats with adjuvant-induced disease, either untreated or receiving trimethazone, phenylbutazone, indometacin, or 6-mercaptopurine. Apart from typical clinical symptoms, the adjuvant-induced disease was characterized by an increase in the number of active nucleoli in the lymphocytes present in the peripheral blood of the diseased animals. This increase was influenced by the administration of any of the drugs enumerated.
Similar content being viewed by others
References
Busch, H., Smetana, K.: The Nucleolus. New York-London: Academic Press 1970.
Pearson, C. M.: Experimental joint disease. J. Chron. Dis. 16, 863–874 (1963).
Pearson, C. M., Wood, F. D.: Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Amer. J. Path. 42, 73–95 (1963).
Scheffe, H.: The Analysis of Variance. New York-London: Wiley, Chapman & Hall 1959.
Schermer, S.: Die Blutmorphologie der Laboratoriumstiere, 2. Aufl. Leipzig: J. A. Barth 1958.
Smetana, K.: Basic histochemical and cytochemical methods. In: Methods in Cancer Research, H. Busch (ed.), vol. 2, pp. 361–443. New York: Academic Press 1967.
Smetana, K., Lejnar, J., Potměšil, M.: A further contribution to the demonstration of RNA and nucleoli of blood cells in smear preparations. Folia haemat. 91, 381–394 (1969).
Waksman, B. H., Pearson, C. M., Sharp, J. T.: Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. J. Immunol. 85, 403–417 (1960).
Winter, C. A., Nuss, G. W.: Treatment of adjuvant arthritis in rats with antiinflammatory drugs. Arthr. and Rheum. 9, 394–404 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Likovský, Z., Grimová, J., Dlabač, A. et al. Morphological changes in nucleoli of lymphocytes and their influencing by trimethazone, phenylbutazone, indometacin, and 6-mercaptopurine in albino rats with adjuvant-induced disease. Naunyn-Schmiedeberg's Arch. Pharmacol. 276, 181–186 (1973). https://doi.org/10.1007/BF00501190
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501190